Return to top of page

Alliance Voice CMS Concerns, The Truth About Alcohol is Revealed, and FDA Advisory Committee are Urged to Listen to Patients

Living Longer and Loving It

People Living With Early Alzheimer's
Need President Biden’s Help

“CMS’ decision effectively cut off access for the vast majority of beneficiaries living with early Alzheimer's...”

For more than a year, the Centers for Medicare & Medicaid Services (CMS) has refused to cover an entire class of FDA-approved therapies for the treatment of mild cognitive impairment and early dementia due to Alzheimer's disease.

In an op-ed for Real Clear Health, Alliance CEO and President Sue Peschin voiced her concern about CMS' decision and its implications on individuals living with Alzheimer's. The op-ed has been re-run in a variety of publications including this Spanish translation, Las personas que vivien con Alzheimer temprano necesitan la ayuda del presidente Biden in the Imperial Valley Press.

CMS coverage policy is detrimental to Alzheimer’s patients via (PhRMA)

Op-ed by our partners at the Global Alzheimer’s Platform: Mr. President, do the right thing for Alzheimer’s Patients (Dallas Examiner)

Medicine pills laying on top of a $100 dollar bill

Living Longer & Loving It is Now Online!

We at the Alliance for Aging Research work hard to provide you with the latest information on research, advocacy, and health policy topics.  Now, you can access our monthly round-up directly from the source.

Keep up with breaking news, events, interviews and more in our new Living Longer & Loving it archive.

Podcast: The Truth About Alcohol
with Dr. George F. Koob, Director of the National Institute on Alcohol Abuse and Alcoholism

April is Alcohol Awareness Month, a time to address the stigma around alcohol use disorder (AUD). Among the millions of Americans impacted, older adults remain at heightened risk of alcohol abuse due to a variety of environmental, medical, and social factors.  

Joining us to discuss the risks of alcohol abuse as we age is the Director of the National Institute on Alcohol Abuse and Alcoholism,
Dr. George F. Koob. 

Listen to the Podcast

Alliance and Partners Urge FDA Advisory Committee to Listen to Alzheimer’s Patients and Families 

The Alliance for Aging Research and the American Society of Consultant Pharmacists (ASCP) submitted a sign-on letter asking the FDA and two of its Advisory Committees to consider patient, family, and provider perspectives as they discuss a proposed expansion of the brexpiprazole label for agitation associated with Alzheimer's disease.

Read Public Comment Delivered by Alliance
President & CEO Sue Peschin

Medicine pills laying on top of a $100 dollar bill

Chairman’s Blog: Our Vaccination Vigilance Should Continue
When the PHE Ends

"Health care professionals warn us that COVID itself could
strongly rebound..."

On May 11, the COVID-19 Public Health Emergency (PHE) will officially end putting a hard stop to a range of government programs designed to blunt the disease's economic, social, and medical impact.

In his latest blog, Alliance Board Chair Jim Scott shares his thoughts on COVID prevention as we approach the next chapter in the pandemic.

Read More

Recent News 

In Medicare Drug Price Negotiations, Avoid Metrics Steeped In Stigma

Health Affairs, April 24

Exclusive: Lilly Expects US Medicare to Reverse Course, Fully Cover Alzheimer's Drugs

Reuters, April 21

The Rate of Older Californians Dying of Malnutrition Has Accelerated

 KFF Health News, April 13

Meet the 106-Year-Old Woman Keeping an Ancient Filipino Tattooing Tradition Alive

Vogue, April 7

Join Our Social Networks

Visit Alliance for Aging Research on Facebook Visit Alliance for Aging Research on Twitter Visit Alliance for Aging Research on YouTube Visit Alliance for Aging Research on Instagram